¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Interleukin-2 Receptor beta Subunit"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
Interleukin-10 Receptor beta Subunit
Interleukin-18 Receptor beta Subunit
Interleukin-12 Receptor beta 1 Subunit
Interleukin-12 Receptor beta 2 Subunit
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
neuromuscular receptor
½Å°æ±Ù(À°)¼ö¿ëü
nicotinic receptor
´ÏÄÚÆ¾¼ö¿ëü
olfactory receptor
Èİ¢¼ö¿ë±â
opiate receptor
¾ÆÆíÁ¦¼ö¿ëü
opioid receptor
¾ÆÆíÀ¯»çÁ¦¼ö¿ëü
postsynaptic receptor
½Ã³À½ºÈļö¿ëü, ¿¬Á¢Èļö¿ëü
prejunctional receptor
Á¢ÇÕÀü¼ö¿ëü
pressor receptor
½Â¾Ð¼ö¿ë±â
paciniform receptor
ÆÄÄ¡´ÏÇü¼ö¿ë±â
progesterone receptor
ÇÁ·Î°Ô½ºÅ׷мö¿ëü
receptor
1. ¼ö¿ëü 2. ¼ö¿ë±â
receptor autoradiography
¼ö¿ëüÀÚ°¡Á¶Á÷¹æ»ç¼±ÃÔ¿µ(¼ú)
receptor binding
¼ö¿ëü°áÇÕ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
receptor cell
¼ö¿ëü¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
kinesthetic receptor
¿îµ¿°¨°¢¼ö¿ëü
labyrinthine receptor
¹Ì·Î¼ö¿ëü
muscarinic receptor
¹«½ºÄ«¸°¼ö¿ëü
neuromuscular receptor
½Å°æ±ÙÀ°¼ö¿ëü
nicotinic receptor
´ÏÄÚÆ¾¼ö¿ëü
olfactory receptor
Èİ¢¼ö¿ëü
opiate receptor
¾ÆÆí¼ö¿ëü
opioid receptor
¾ÆÆíÀ¯»ç¹°Áú¼ö¿ëü
paciniform receptor
ÆÄÄ¡´ÏÇü¼ö¿ëü
postsynaptic receptor
¿¬Á¢Èļö¿ëü
prejunctional neuromuscular receptor
½Å°æ±ÙÀ°Á¢ÇÕÀü¼ö¿ëü
pressor receptor
¾Ð·Â¼ö¿ëü
receptor potential
°¨¼ö±âÀüÀ§, °¨¼ö±âÀü¾Ð, ¼ö¿ëüÀü¾Ð
receptor
¼ö¿ëü, ¼ö¿ë±â
receptor site
¼ö¿ëüºÎÀ§
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
receptor assay
¼ö¿ëÃ¼ÃøÁ¤
receptor autoradiography
¼ö¿ëü ÀÚ±â¹æ»ç¼±ÃÔ¿µ¼ú
receptor binding
¼ö¿ëü°áÇÕ
receptor blockade
¼ö¿ëüÂ÷´Ü
receptor blocking agent
¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
receptor cell
¼ö¿ëü ¼¼Æ÷
receptor destroying enzyme
¼ö¿ëüÆÄ±«È¿¼Ò(¡÷òÎÕý£áÈ).
receptor gradient
¼ö¿ëü°æ»ç.
receptor hypothesis
¼ö¿ëü°¡¼³
receptor imaging
¼ö¿ëü¿µ»ó(È)
receptor organ
¼ö¿ë±â°ü(áôé»Ðïί).
receptor potential
¼ö¿ë±âÀüÀ§.
receptor sensitivity
¼ö¿ëü °¨¼ö¼º
receptor site
¼ö¿ëüºÎÀ§.
receptor stimulants
¼ö¿ëüÀÚ±ØÁ¦.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
beta-lactamase inhibitors
º£Å¸-¶ôޯı«È¿¼Ò¾ïÁ¦Á¦.
beta-lipoprotein
º£Å¸-Áö´Ü¹é<--ÁöÁú´Ü¹éÁú>
beta-lipoproteinemia
º£Å¸-Áö¹æ´Ü¹éÇ÷Áõ
beta-microglobulin
b-¹ÌÅ©·Î±Û·ÎºÒ¸°
beta-naphthylamine
º£Å¸³ªÇÁÆ¿¾Æ¹Î
beta-sitosterolemia
º£Å¸-½ÃÅ佺Å×·ÑÇ÷Áõ
beta-toxin
º£Å¸µ¶¼Ò(¡Ô¸áÈ)
broad beta disease
±¤º£Å¸º´
cardioselective beta-adrenoreceptor blocker
½ÉÀå ¼±Åüº º£Å¸Â÷´ÜÁ¦(ãýíôàÔ÷Éàõ - ó´Ó¨ð¥)
chain, beta (¥â)
º£Å¸»ç½½, º£Å¸¼â
cystathionine beta-synthase
½Ã½ºÅ¸Æ¼¿À´Ñº£Å¸ÇÕ¼ºÈ¿¼Ò
delta-beta thalassmia
µ¨Å¸-º£Å¸ ÁöÁßÇØºóÇ÷
dopamine-beta-hyroxylase
µµÆÄ¹Î º£Å¸ È÷µå·Ï½Ç¶óÁ¦
gamma-delta-beta thalassemia
°¨¸¶-µ¨Å¸-º£Å¸- ÁöÁßÇØ¼ººóÇ÷
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½